New Data, New Opportunities, and New Clinical Challenges Using Immunotherapies for TNBC

Get up to date on the latest advances in immunotherapies for TNBC across multiple settings with expert commentaries, downloadable slides, and on-demand Webcast capturing a live CCO panel presentation.
Heather McArthur, MD, MPH
Program Director
Kevin Kalinsky, MD, MS
Rita Nanda, MD

On-Demand Webcast

In this interactive recording of a live CCO Webinar, a dynamic expert panel discusses the latest data on optimal use of immune checkpoint inhibitors and antibody–drug conjugates for treating patients with early-stage through metastatic TNBC.

Heather McArthur, MD, MPH
Program Director
Kevin Kalinsky, MD, MS Rita Nanda, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits ABIM MOC: maximum of 1.25 Medical Knowledge MOC point(s) Released: January 22, 2021 Expired: January 21, 2022
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Genentech, a member of the Roche Group
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue